Cresco Labs Inc. (CRLBF)

Market Cap	285.45M
Revenue (ttm)	661.62M
Net Income (ttm)	-52.19M
Shares Out	n/a
EPS (ttm)	-0.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,050,200
Average Volume	589,238
Open	0.8300
Previous Close	0.8950
Day's Range	0.8000 - 0.8790
52-Week Range	0.4256 - 1.6200
Beta	1.89
RSI	32.53
Earnings Date	Nov 5, 2025

About Cresco Labs

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers canna...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 2,900
• Stock Exchange: OTCMKTS
• Ticker Symbol: CRLBF

Financial Performance

In 2024, Cresco Labs's revenue was $715.76 million, a decrease of -5.33% compared to the previous year's $756.06 million. Losses were -$74.44 million, -57.59% less than in 2023.